Molecular mechanism of leukocyte activation by galectin via integrin family
Molecular mechanism of leukocyte activation by galectin via integrin family
批准号:
17570116
负责人:
NAKAMURA Takanori
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Galectins are members of an animal lectin family, which specifically recognizes P-galactoside structure of glycoconjugates. In this study, we attempted to analyze the molecular mechanism of the functions and their signaling of tandem repeat galectins, such as galectins-8 and-9 in immune cells. First, we compared the effects of galectins-8 and-9on the apoptosis and cell adhesion in various immune cell lines. Galectin-9 induced apoptosis of Tell lines (Jurkat and Molt-4), but galectin-8 did not Both of galectins mediated the cell adhesion to plastic culture plates in B-cell lines(Namalwa, and RPM-8866) and a monocytic cell (THP-1) in addition of T-cell lines. In the present study, we examined the properties of galectin-9-mediated cell death of Jurkat T-cells. Galectin-9NC (wild-type), consisting of two CRDs (N-terminal and C-terminal carbohydrate recognition domains), and derivatives of it, galectins-9-NN and-9-CC, induced Jurkat T-cell apoptosis. However, a single CRD (galectin-9NT or-CT) had no effect, suggesting the stable dimeric structure of two CRDs is required for the activity. The apoptosis was inhibited by pretreatment with an N-glycan synthesis inhibitor, indicating that the expression of N-glycans in the cells is essential for galectin-9-induced apoptosis. We previously showed that the apoptosis of MOLT-4 cell is mediated by galectin-9 via a Ca^<2+>-calpain-caspase-1-dependent pathway. In Jurkat cells, the cell death by galectin-9, was insufficiently suppressed by caspase inhibitors, Ca^<2+>-chelator or calpain inhibitor. Furthermore, we observed the loss of mitochondrial membrane potential and significant AIF release in galectin-9-treated cells. These findings suggest that caspase-dependent and-independent death pathways exist in Jurkat cells, and the main pathway might vary with the T-cell type.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1158/1078-0432.ccr-04-0861
发表时间:
2005-04-15
期刊:
CLINICAL CANCER RESEARCH
影响因子:
11.5
作者:
[Irie, A, Yamauchi, A, Hirashima, M]
通讯作者:
Hirashima, M
Crystal structure of the galectin-9 N-terminal carbohydrate recognition domain from MUS musculus reveals basic mechanism of carbohydrate recognition.
MUS musculus 半乳糖凝集素 9 N 末端碳水化合物识别结构域的晶体结构揭示了碳水化合物识别的基本机制。
DOI:
--
发表时间:
2006
期刊:
J. Biol. Chem. 281
影响因子:
--
作者:
[佐藤ちひろ, 北島 健, 佐藤ちひろ, Helle F.Jorgensen, Toru Sato, Yu-ichi Fujimura, 遠藤充浩, Kyo-ichi Isono, Kyo-ichi Isono, L.-H.Lu et al., N.Miyanishi et al., M.Nagae et al.]
通讯作者:
M.Nagae et al.
Carbohydrate-recognition domains of galectin-9 are involved in intermolecular interaction with galectin-9 itself and other members of the galectin family.
半乳糖凝集素 9 的碳水化合物识别域参与半乳糖凝集素 9 本身和半乳糖凝集素家族其他成员的分子间相互作用。
DOI:
--
发表时间:
2007
期刊:
Glycobiology 17
影响因子:
--
作者:
[佐藤ちひろ, 北島 健, 佐藤ちひろ, Helle F.Jorgensen, Toru Sato, Yu-ichi Fujimura, 遠藤充浩, Kyo-ichi Isono, Kyo-ichi Isono, L.-H.Lu et al., N.Miyanishi et al.]
通讯作者:
N.Miyanishi et al.
ガレクチンの標的分子を捜せ
寻找半乳糖凝集素靶分子
DOI:
--
发表时间:
2005
期刊:
生化学 77
影响因子:
--
作者:
[中村隆範, 西 望]
通讯作者:
西 望
DOI:
10.1016/j.febslet.2005.02.054
发表时间:
2005-04-11
期刊:
FEBS LETTERS
影响因子:
3.5
作者:
[Nishi, N, Itoh, A, Nakamura, T]
通讯作者:
Nakamura, T
共 9 条
Molecular mechanisms that maintain centrosome integrity by SAPK and mechanisms that regulate PLK4 localization to centrosomes.
-
批准号:25893039
-
项目类别:Grant-in-Aid for Research Activity Start-up
-
资助金额:$1.41万
-
财政年份:2013
-
负责人:NAKAMURA Takanori
-
依托单位:
Identification of cell adhesion molecules and growth factors in the serum & the development of new culture medium
-
批准号:23651222
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:NAKAMURA Takanori
-
依托单位:
Analysis of the role of galectin family and its signaling in the host-response to infection and inflammation.
-
批准号:15570120
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2003
-
负责人:NAKAMURA Takanori
-
依托单位:
Functional analysis on follistatin domain-containing proteins and activin signaling
-
批准号:09680626
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:1997
-
负责人:NAKAMURA Takanori
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Gal9+TAMs经旁分泌塑造新型Gal9-Met互作轴驱动肝癌免疫逃逸的分子机制及干预策略
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:杨文静
-
依托单位:
Galectin-9诱导调节性T细胞分化在川崎病中减轻冠脉损伤机制研究
-
批准号:JCZRYB202501200
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
CAFs通过Galectin-9介导T细胞排斥及肺
癌新辅助免疫治疗抵抗
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:侯雪
-
依托单位:
Galectin-9诱导的调节性T细胞通过激活 TGFß/NFATc2/galectin-9正反馈环维持肺癌肿瘤干细胞干性和免疫抑制微环境的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:肖芷洁
-
依托单位:
MARCO+ 巨噬细胞分泌Galectin-9促进脂肪组织胰岛素抵抗的作用
及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:袁月
-
依托单位:
新型树突状细胞检查点 Siglec-10 通过 Galectin-9 诱导 CD8+T 细胞耗竭促进宫
颈癌免疫逃逸的机制研究
-
批准号:24ZR1407600
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:汪雨萌
-
依托单位:
CEACAM5调控Galectin-9介导的CD4+T细胞极化在COVID-19肠屏障损伤的作用机制研究
-
批准号:82370569
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:李啸峰
-
依托单位:
CXCL13通过干扰素信号通路促进肿瘤相关巨噬细胞分泌Galectin-9介导胃癌免疫逃逸的机制研究
-
批准号:82303313
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:魏依绸
-
依托单位:
Galectin-9/Tim-3通路通过调控巨噬细胞M1/M2极化抑制心脏移植急性排斥反应的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位:
小胶质细胞来源Galectin-9在阿尔茨海默病中的作用和机制研究
-
批准号:82301598
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:张国新
-
依托单位: